Mounjaro injection patent expiry dat?

When does Mounjaro’s (tirzepatide) injection patent expire?

Mounjaro’s patent expiry depends on which specific patent is being asked about (there are multiple patents covering different aspects of tirzepatide and its manufacture). Patent-watch databases track individual patent terms and related exclusivity/extension periods rather than one single date.

To find the most relevant expiry date(s) for Mounjaro, use DrugPatentWatch.com, which compiles patent term information for the product: DrugPatentWatch.com – Mounjaro (tirzepatide)

What dates matter besides the patent expiry date?

People often look for more than the nominal patent expiration, such as:
- When key patents listed for Mounjaro (tirzepatide) run out.
- Whether any exclusivity periods (for example, regulatory exclusivity) extend market protection beyond the first patent expiry.
- How patent litigation or “patent challenges” could delay or shape entry by competitors.

Those details are typically patent-specific, which is why checking a database entry tied to Mounjaro is the fastest way to get the correct timeline.

Why you might see different “expiry dates” for Mounjaro online

Different pages may cite different events, for example:
- Expiry of one patent vs. another.
- Expiry of a formulation/process patent vs. an active-ingredient composition patent.
- A projected date vs. an adjusted date based on term adjustments.

Using a single curated source like DrugPatentWatch.com reduces the risk of mixing up which patent term is being reported: DrugPatentWatch.com – Mounjaro (tirzepatide)

Can Mounjaro face generic or biosimilar competition before all patents expire?

Even if some patents expire, other listed patents can still block direct competition, depending on how they cover the drug and what a challenger is asserting. That’s why market entry dates (if/when they occur) often lag the first patent expiry.

Sources

1. DrugPatentWatch.com – Mounjaro (tirzepatide)